217 related articles for article (PubMed ID: 33596124)
1. Injecting substance use in prisons in the United States: a case for needle exchange programs.
Armstrong-Mensah E; Dada D; Rupasinghe R; Whately H
Am J Drug Alcohol Abuse; 2021 May; 47(3):273-279. PubMed ID: 33596124
[TBL] [Abstract][Full Text] [Related]
2. HIV in prison: what are the risks and what can be done?
Hellard ME; Aitken CK
Sex Health; 2004; 1(2):107-13. PubMed ID: 16334992
[TBL] [Abstract][Full Text] [Related]
3. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
[TBL] [Abstract][Full Text] [Related]
4. [The place of syringe exchange programs in reducing harm in Canadian prisoners].
Orsi MM; Brochu S
Can J Public Health; 2009; 100(1):29-31. PubMed ID: 19263972
[TBL] [Abstract][Full Text] [Related]
5. A Senior Management Perspective on the Policy Debate of Needle and Syringe Exchange Program Provision in Irish Prisons.
Rosalim JP
J Correct Health Care; 2020 Jan; 26(1):27-35. PubMed ID: 31983260
[TBL] [Abstract][Full Text] [Related]
6. Injecting drug use in prison: prevalence and implications for needle exchange policy.
Wright NM; Tompkins CN; Farragher TM
Int J Prison Health; 2015; 11(1):17-29. PubMed ID: 25751704
[TBL] [Abstract][Full Text] [Related]
7. PrEP in Prisons: HIV prevention in incarcerated populations.
Parsons J; Cox C
Int J Prison Health; 2019 Nov; 16(2):199-206. PubMed ID: 32378831
[TBL] [Abstract][Full Text] [Related]
8. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
Chakrapani V; Kamei R; Kipgen H; Kh JK
Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
[TBL] [Abstract][Full Text] [Related]
10. The Global State of Harm Reduction in Prisons.
Sander G; Shirley-Beavan S; Stone K
J Correct Health Care; 2019 Apr; 25(2):105-120. PubMed ID: 31084277
[TBL] [Abstract][Full Text] [Related]
11. [Risk reduction and drug use in detention: study about the detainees of Liancourt Penitentiary].
Sannier O; Verfaillie F; Lavielle D
Presse Med; 2012 Jul; 41(7-8):e375-85. PubMed ID: 22386285
[TBL] [Abstract][Full Text] [Related]
12. Drug use and risk of bloodborne infections: a survey of female prisoners in British Columbia.
Martin RE; Gold F; Murphy W; Remple V; Berkowitz J; Money D
Can J Public Health; 2005; 96(2):97-101. PubMed ID: 15850026
[TBL] [Abstract][Full Text] [Related]
13. Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour.
Izenberg JM; Bachireddy C; Wickersham JA; Soule M; Kiriazova T; Dvoriak S; Altice FL
Int J Drug Policy; 2014 Sep; 25(5):845-52. PubMed ID: 24951025
[TBL] [Abstract][Full Text] [Related]
14. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; Stöver H; Dolan K; Vickerman P
Lancet; 2016 Sep; 388(10050):1228-48. PubMed ID: 27427455
[TBL] [Abstract][Full Text] [Related]
15. "It Goes on Everywhere": Injection Drug Use in Canadian Federal Prisons.
van der Meulen E
Subst Use Misuse; 2017 Jun; 52(7):884-891. PubMed ID: 28426354
[TBL] [Abstract][Full Text] [Related]
16. The furthest left behind: the urgent need to scale up harm reduction in prisons.
Sander G; Murphy F
Int J Prison Health; 2017 Sep; 13(3-4):185-191. PubMed ID: 28914120
[TBL] [Abstract][Full Text] [Related]
17. A review of medical and substance use co-morbidities in Central Asian prisons: implications for HIV prevention and treatment.
Vagenas P; Azbel L; Polonsky M; Kerimi N; Mamyrov M; Dvoryak S; Altice FL
Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S25-31. PubMed ID: 23932844
[TBL] [Abstract][Full Text] [Related]
18. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
Takács IG; Demetrovics Z
Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
[TBL] [Abstract][Full Text] [Related]
20. U.S. prisons fail to adopt proven prevention measures, experts say.
AIDS Policy Law; 1997 Apr; 12(6):1, 9-10. PubMed ID: 11364177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
